WallStreetZenWallStreetZen

NASDAQ: NKTR
Nektar Therapeutics Stock Ownership - Who owns Nektar Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Nektar Therapeutics insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Mark Andrew WilsonChief Legal Officer2024-02-207,606$0.68
$5.17kSell
Jonathan ZalevskyChief RD Officer2024-02-209,014$0.68
$6.13kSell
Howard W. RobinPresident CEO2024-02-2020,033$0.68
$13.62kSell
Mark Andrew WilsonChief Legal Officer2023-11-177,179$0.49
$3.52kSell
Jonathan ZalevskyChief RD Officer2023-11-179,646$0.49
$4.73kSell
Howard W. RobinPresident CEO2023-11-1719,877$0.49
$9.74kSell
Jeffrey Robert AjerDirector2023-09-184,359$0.69
$3.01kSell
Myriam CuretDirector2023-09-184,359$0.69
$3.01kSell
Jonathan ZalevskyChief RD Officer2023-08-169,703$0.78
$7.57kSell
Howard W. RobinPresident CEO2023-08-1619,998$0.78
$15.60kSell

1 of 2

NKTR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NKTR insiders and whales buy or sell their stock.

NKTR Shareholders

What type of owners hold Nektar Therapeutics stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Deep Track Capital LP10.02%18,400,000$24.84MInsider
Deep Track Capital LP10.02%18,400,000$24.84MInstitution
Vanguard Group Inc6.56%12,042,873$16.26MInstitution
Acadian Asset Management LLC4.26%7,818,804$10.56MInstitution
Primecap Management Co3.81%7,001,747$9.45MInstitution
Blackrock Inc3.32%6,104,217$8.24MInstitution
Monaco Asset Management Sam3.25%5,973,387$8.06MInstitution
Citadel Advisors LLC3.06%5,625,000$7.59MInstitution
Renaissance Technologies LLC2.90%5,325,475$7.19MInstitution
Gsa Capital Partners LLP2.86%5,255,790$7.10MInstitution

1 of 3

NKTR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NKTR64.89%14.15%Net SellingNet Selling
XBIT11.32%45.18%
PBYI55.20%44.43%Net Selling
ACRV46.35%53.65%Net BuyingNet Buying
INO61.56%38.44%Net SellingNet Selling
View Top Biotech Stocks

Nektar Therapeutics Stock Ownership FAQ

Who owns Nektar Therapeutics?

Nektar Therapeutics (NASDAQ: NKTR) is owned by 64.89% institutional shareholders, 14.15% Nektar Therapeutics insiders, and 20.96% retail investors. Deep Track Capital LP is the largest individual Nektar Therapeutics shareholder, owning 18.40M shares representing 10.02% of the company. Deep Track Capital LP's Nektar Therapeutics shares are currently valued at $24.29M.

If you're new to stock investing, here's how to buy Nektar Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.